![AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease - The Economic Times AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease - The Economic Times](https://img.etimg.com/thumb/msid-80722963,width-1200,height-900,imgsize-360331,overlay-economictimes/photo.jpg)
AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney disease - The Economic Times
![Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC](http://www.dicardiology.com/sites/default/files/COVID_Forxinga_dapagliflozin_ACC21.jpg)
Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC
![Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy | Cardiovascular Diabetology | Full Text Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-019-0980-4/MediaObjects/12933_2019_980_Fig6_HTML.png)
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy | Cardiovascular Diabetology | Full Text
![AstraZeneca Forxiga 10 mg Tablet, Dapagliflozin, Packaging Type: Strip, Rs 730/strip | ID: 20867101548 AstraZeneca Forxiga 10 mg Tablet, Dapagliflozin, Packaging Type: Strip, Rs 730/strip | ID: 20867101548](https://5.imimg.com/data5/TestImages/LC/FS/OM/SELLER-30957396/forxiga-10-mg-tablet-dapagliflozin-500x500.jpeg)